These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39096589)

  • 1. Implementation of a financial navigation program in gynecologic oncology.
    Noor Chelsea N; Posever N; Hsieh TYJ; Patterson S; Sweeney C; Dalrymple JL; Dottino J; Wiechert AC; Garrett L; Hacker MR; Esselen KM
    Gynecol Oncol; 2024 Oct; 189():119-124. PubMed ID: 39096589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a Comprehensive Financial Navigation Intervention to Reduce Cancer-Related Financial Toxicity.
    Wheeler SB; Manning ML; Gellin M; Padilla N; Spees LP; Biddell CB; Petermann V; Deal A; Rogers C; Rodriguez-O'Donnell J; Samuel-Ryals C; Reeder-Hayes K; Rosenstein DL
    J Natl Compr Canc Netw; 2024 Oct; 22(8):557-562. PubMed ID: 39413831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic social resource needs screening in the gynecologic oncology clinic: a quality improvement initiative.
    Beavis AL; Sanneh A; Stone RL; Vitale M; Levinson K; Rositch AF; Fader AN; Topel K; Abing A; Wethington SL
    Am J Obstet Gynecol; 2020 Nov; 223(5):735.e1-735.e14. PubMed ID: 32433998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessening the Impact of Financial Toxicity (LIFT): a protocol for a multi-site, single-arm trial examining the effect of financial navigation on financial toxicity in adult patients with cancer in rural and non-rural settings.
    Wheeler SB; Biddell CB; Manning ML; Gellin MS; Padilla NR; Spees LP; Rogers CD; Rodriguez-O'Donnell J; Samuel-Ryals C; Birken SA; Reeder-Hayes KE; Petermann VM; Deal AM; Rosenstein DL
    Trials; 2022 Oct; 23(1):839. PubMed ID: 36192802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot Feasibility Study of an Oncology Financial Navigation Program.
    Shankaran V; Leahy T; Steelquist J; Watabayashi K; Linden H; Ramsey S; Schwartz N; Kreizenbeck K; Nelson J; Balch A; Singleton E; Gallagher K; Overstreet K
    J Oncol Pract; 2018 Feb; 14(2):e122-e129. PubMed ID: 29272200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insurance-based disparities and risk of financial toxicity among patients undergoing gynecologic cancer operations.
    Ng AP; Sanaiha Y; Verma A; Lee C; Akhavan A; Cohen JG; Benharash P
    Gynecol Oncol; 2022 Aug; 166(2):200-206. PubMed ID: 35660294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial toxicity in gynecologic oncology: a multi-practice survey.
    Smith AJ; Sharma MH; Powell K; Doherty M; Hinkle SN; Ko EM
    Int J Gynecol Cancer; 2024 Jun; 34(6):919-925. PubMed ID: 38346844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.
    Hahn EE; Munoz-Plaza CE; Pounds D; Lyons LJ; Lee JS; Shen E; Hong BD; La Cava S; Brasfield FM; Durna LN; Kwan KW; Beard DB; Ferreira A; Padmanabhan A; Gould MK
    JAMA; 2022 Jan; 327(1):41-49. PubMed ID: 34982119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
    Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
    Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial Assistance Processes and Mechanisms in Rural and Nonrural Oncology Care Settings.
    Biddell CB; Spees LP; Petermann V; Rosenstein DL; Manning M; Gellin M; Padilla N; Samuel-Ryals CA; Birken SA; Reeder-Hayes K; Deal AM; Cabarrus K; Bell RA; Strom C; DeAntonio PA; Young TH; King S; Leutner B; Vestal D; Wheeler SB
    JCO Oncol Pract; 2022 Sep; 18(9):e1392-e1406. PubMed ID: 35549521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer risk and screening among women seeking assistance with basic needs.
    Kuroki LM; Massad LS; Woolfolk C; Thompson T; McQueen A; Kreuter MW
    Am J Obstet Gynecol; 2021 Apr; 224(4):368.e1-368.e8. PubMed ID: 33316278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core functions of a financial navigation intervention: An in-depth assessment of the Lessening the Impact of Financial Toxicity (LIFT) intervention to inform adaptation and scale-up in diverse oncology care settings.
    Wheeler SB; Birken SA; Wagi CR; Manning ML; Gellin M; Padilla N; Rogers C; Rodriguez J; Biddell CB; Strom C; Bell RA; Rosenstein DL
    Front Health Serv; 2022; 2():958831. PubMed ID: 36925862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crowdsourcing to measure financial toxicity in gynecologic oncology.
    Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
    Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for financial toxicity in patients with gynecologic cancer.
    Aviki EM; Manning-Geist BL; Sokolowski SS; Newman T; Blinder VS; Chino F; Doyle SM; Liebhaber A; Gordhandas SB; Brown CL; Broach V; Chi DS; Jewell EL; Leitao MM; Long Roche K; Mueller JJ; Sonoda Y; Zivanovic O; Gardner GJ; Abu-Rustum NR
    Am J Obstet Gynecol; 2022 Jun; 226(6):817.e1-817.e9. PubMed ID: 34902319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
    Liang MI; Pisu M; Summerlin SS; Boitano TKL; Blanchard CT; Bhatia S; Huh WK
    Gynecol Oncol; 2020 Feb; 156(2):271-277. PubMed ID: 31771866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Institutional Study of Referral Patterns for Gynecologic Oncology Consultation.
    DeMari JA; Madeka I; Evans JK; Bailey C; Bartucci K; Bottsford-Miller J; Bradford L; Burnett B; Kelly R; Rowland M; Wallbillich JJ; Shalowitz DI
    JCO Oncol Pract; 2024 Sep; 20(9):1198-1206. PubMed ID: 38776512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black and hispanic women have less support during cancer evaluation and treatment: results from a prospective patient reported outcomes program in gynecologic malignancy.
    Philp L; Alimena S; Sullivan M; Del Carmen M; Bregar A; Eisenhauer E; Goodman A; Sisodia RC
    Int J Gynecol Cancer; 2023 May; 33(5):770-777. PubMed ID: 36639193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dedicated financial hardship screening adds value to routine distress screening among gynecologic cancer patients.
    Liang MI; Dholakia JD; Lee GM; Wang L; Kako TD; Blair I; Williams CP; Arend RC; Huh WK; Rocque GB; Pisu M
    Gynecol Oncol; 2024 Apr; 183():53-60. PubMed ID: 38518528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Family Navigation on Diagnostic Ascertainment Among Children at Risk for Autism: A Randomized Clinical Trial From DBPNet.
    Feinberg E; Augustyn M; Broder-Fingert S; Bennett A; Weitzman C; Kuhn J; Hickey E; Chu A; Levinson J; Sandler Eilenberg J; Silverstein M; Cabral HJ; Patts G; Diaz-Linhart Y; Fernandez-Pastrana I; Rosenberg J; Miller JS; Guevara JP; Fenick AM; Blum NJ
    JAMA Pediatr; 2021 Mar; 175(3):243-250. PubMed ID: 33427861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.